Seattle Washington based Oisin Biotechnologies is raising $9,531,422.00 in New Equity Investment.
Seattle, WA – According to filings with the U.S. Securities and Exchange Commission, Oisin Biotechnologies is raising $9,531,422.00 in new funding. Sources indicate as part of senior management President, Matthew Scholz played a key role…